Marcos Tassano
Montevideo, MO, Uruguay
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Theranostic Radiotracers for Melanoma Imaging and Therapy: A Comparative Study of Subcutaneous and Intradermal Tumor Models Using DOTA-Re-CCMSH Peptides.
Journal: Cancer biotherapy & radiopharmaceuticals
Published: May 23, 2025
Theranostic Potential of [177Lu]Lu-DOTA-Tocilizumab in Multiple Myeloma: A Preclinical Evaluation.
Journal: Anti-cancer agents in medicinal chemistry
Published: May 21, 2025
Molecular Imaging of Melanoma VEGF-expressing Tumors through [99mTc]Tc-HYNIC-Fab(Bevacizumab).
Journal: Anti-cancer agents in medicinal chemistry
Published: April 08, 2024
Preclinical Evaluation of 99mTc-Labeled LHRH Analog as Cancer Receptor Imaging.
Journal: Oncology
Published: January 29, 2024
Enhanced Tumor Targeting of Radiolabeled Mouse/Human Chimeric Anti-Tn Antibody in Losartan-Treated Mice Bearing Tn-Expressing Lung Tumors.
Journal: Cancer biotherapy & radiopharmaceuticals
Published: January 12, 2024
Mitofusin 1 silencing decreases the senescent associated secretory phenotype, promotes immune cell recruitment and delays melanoma tumor growth after chemotherapy.
Journal: Scientific reports
Published: August 17, 2023
Evaluation of chromosomal aberrations induced by 188Re-dendrimer nanosystem on B16f1 melanoma cells.
Evaluation of chromosomal aberrations induced by 188Re-dendrimer nanosystem on B16f1 melanoma cells.
Journal: International journal of radiation biology
Published: May 19, 2018
Development of (177)Lu-DOTA-Dendrimer and Determination of Its Effect on Metal and Ion Levels in Tumor Tissue.
Journal: Cancer biotherapy & radiopharmaceuticals
Published: December 02, 2015
Labeling polyamidoamine (PAMAM) dendrimers with technetium-99m via hydrazinonicotinamide (HYNIC).
Journal: Current radiopharmaceuticals
Published: May 10, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026